The apolipoprotein E gene (APOE) polymorphism genotyping has an allegedly important predictive value for coronary heart disorders and Alzheimer disease. We developed a simple, fast, cost-effective and suited for high-throughput protocol for determining APOE genotypes by Real Time PCR monitored by SYBR ® Green. The method is based on differential amplification by allele-specific primers. These primers have variations in their 3´-end nucleotides such that are specific for one of the two variants in each polymorphic position. By this protocol, we obtained a 100%
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Introduction
Apolipoprotein E (ApoE) is a 34 kDa glycoprotein involved in lipid metabolism (Mahley, 1988) . The human APOE gene coding for this protein is polymorphic and is located on chromosome 19 (Das et al., 1985) . There are three common codominant alleles2, 3 and 4 that encode three ApoE protein isoforms: E 2 , E 3 and E 4 . These isoforms differ at the amino acid residues 112 and 158. Isoform E 2 has cysteine residues at both sites, E 4 has arginine residues at both sites, while E 3 , the most common form, has a cysteine at position 112 and an arginine at position 158 (Emi et al., 1988 ). These differences have profound effects on the biological functions of ApoE. The lipidbinding activities of these isoforms are different: E 2 and E 3 bind preferentially to HDL, whereas E 4 prefers VLDL (Saito et al., 2003) . These biochemical differences may be responsible for the association of the isoforms with different pathological processes.
The isoform E 4 is associated with a higher risk for coronary heart and Alzheimer´s diseases. In contrast, isoform E 2 shows a protective effect against Alzheimer´s disease, but it is associated with familial type III hyperlipoproteinemia (Roses et al., 1994) .
Thus, interest in APOE genotyping is high for epidemiological research and it is already recognized as valuable information that may help to identify individuals at increased risk for cardiovascular disorders, and it may as well be part of future diagnostic or predictive algorithms for individuals at risk of developing Alzheimer's disease.
Several methods are commonly used for genotyping the three major APOE haplotypes.
The more frequent method has been traditionally PCR-RFLP (PCR-Restriction
Fragment Length Polymorphism) analysis (Zivelin et al., 1997) . However, it is a timeconsuming and error-prone method, due to possible incomplete restriction enzyme 4 digestion. Capillary electrophoresis (Somsen et al., 2002) , PCR plus sequencing or mass spectrometry (Srinivasan et al., 1998) 
Materials and Methods

Subjects
The study was approved by Alzheimer's Disease Research Unit. CIEN FoundationReina Sofia Foundation, Institute of Health Carlos III Ethics Committee with the adequate understanding and written consent of subjects, family members or legal guardians, as appropriate. A total of 280 subjects diagnosed of probable Alzheimer according to NINCDS-ADRDA (McKhann et al., 1984) were analyzed.
Human genomic DNA isolation
Genomic DNA was extracted from 2 ml of human whole blood by NucleoSpin ® Blood L kit (Macherey-Nagel) according to the manufacturer's instructions.
Oligonucleotide primers design
The primers have been designed from human APOE sequence (NG_007084.2, NCBI reference assembly sequence). The forward primers comprise from positions 2886 to 2903, whereas the reverse primers include from positions 3041 to 3058. Their 3´-end nucleotides are located on the polymorphic site, and the specific primers were designed to match one of the two variants at the 2903 and 3041 APOE positions (Table 1) .
DNA amplification by Real Time PCR
The primers were combined in three reaction mixtures to yield a predicted amplification product of 173 bp: "Reaction ApoE2" (primers ApoE_112C and ApoE_158C), "Reaction ApoE3" (primers ApoE_112C and ApoE_158R) and "Reaction ApoE4"
(primers ApoE_112R and ApoE_158R). Each PCR reaction mixture contained the following: 1x Power SYBR ® Green PCR Master Mix (Applied Biosystems), 0.3 µM of each primer and 50 ng of genomic DNA. Negative controls were performed by using the same reaction mixtures without DNA. All the reactions were run in duplicate. The PCR amplification protocol was as follows: initial AmpliTaq Gold DNA Polymerase activation at 95 ºC for 10 min, followed by 40 cycles with denaturation at 95 ºC for 15 s, and annealing+extension at 62 ºC for 1 min. Amplification was performed either on a
StepOne Real Time PCR System (48-well format) (Applied Biosystems), on a 7500
Real Time PCR System (96-well format) (Applied Biosystems), or on a 7900HT Real-6 Time PCR System (384-well format) (Applied Biosystems) by using the comparative C T (C T ) method (quantitation experiment setup).
Standard APOE end-point PCR amplification and sequencing
For validation purposes, all samples genotyped by the above-described Real Time PCR protocol were contrasted by standard end-point PCR amplification and DNA sequencing. In brief, all reactions were carried out with 100 ng of genomic DNA and 1 unit of Taq and Chromas v 2.33 software.
Results and Discussion
In order to monitor in real time DNA amplification, the double-stranded DNAfluorescent dye SYBR ® Green was included in all reactions for APOE genotyping. The "cycle threshold", or Ct value (fixed in the exponential phase of the amplification plot as the number of PCR cycles necessary to achieve a given level of fluorescence) was chosen as the informative Real Time PCR read-out for genotyping results analysis.
By this method and using the experimental conditions described above in a StepOne The difference in the Ct values between positive and negative reactions was in all cases and systems of at least 5 cycles, which indicates that the specific amplifications are more than 32-fold more efficient compared to the non-specific ones. All the samples genotyped by this method showed amplification patterns in perfect concordance with the APOE genotypes determined by sequencing analysis.
In order to explore the versatility and robustness of this genotyping protocol, we studied its applicability to lower amounts of DNA material and smaller reaction volumes. Total final volumes of the PCR reactions from 10 to 1 l were tested. In our hand, volumes down to 2 l were sufficient to distinguish between positive and negative reactions, whereas smaller volumes yielded erratic results, likely due to pipetting errors associated to our automatic volume dispenser system (data not shown). Different initial DNA amounts were tested (from 1 ng up to 50 ng). With decreasing amounts of DNA, we observed that the Ct between positive and negative reactions were similar or smaller, but always sufficient to differentiate them (data not shown).
A number of methods have been developed for APOE genotyping. Traditionally, three methods have been commonly used, namely PCR followed by DNA sequence analysis, PCR followed by RFLP analysis, and PCR followed by Reverse Hybridization.
Sequence analysis is very reliable, but time consuming and expensive method. PCR-RFLP analysis (Zivelin et al., 1997) by mean of digestion of the fragment of the coding region of APOE with HhaI is an inexpensive, but error-prone method, due to possible incomplete restriction enzyme digestion or star activity that difficult the interpretation of results. Reverse Hybridization, as well as other methods recently developed, including capillary electrophoresis (Somsen et al., 2002) , PCR plus sequencing or mass spectrometry (Srinivasan et al., 1998) , and ARMS-PCR (Donohoe et al, 1999) , are valuable and convenient techniques for small-scale investigators, but difficult to scaleup for large number of samples. Ponchel et al. (2003) proposed the use of SYBR Green ® to perform relative quantification of gene rearrangements, gene amplifications and micro gene deletions analysis as alternative to the TaqMan ® methodology (Koch et al., 2002 Polymorphic bases are shown in bold. Ct ( 
